Isoniazid/Piperine/Rifampicin

异烟肼/胡椒碱/利福平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIsoniazid/Piperine/Rifampicin
Drug Alias Namerifampicin, isoniazid and piperineRifampicin/isoniazid/piperineRisorine
ClassificationSmall molecules
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitorsCytochrome P450 3A inhibitorsP-glycoprotein 1 inhibitors
TargetsBacterial DNA-directed RNA polymeraseCytochrome P450 3AP-glycoprotein 1
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes IsoniazidPiperineRifampicin
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCadila Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeJ04AC51
Related LinksN/A